(Q33744238)

English

Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents (English)

1 reference

Europe PubMed Central

29 July 2017

Bacteroides fragilis

object named as

Bacteroides fragilis

1 reference

based on heuristic

inferred from title

author name string

Appelbaum PC

1

1 reference

Europe PubMed Central

29 July 2017

Spangler SK

2

1 reference

Europe PubMed Central

29 July 2017

Jacobs MR

3

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 June 1991

1 reference

Europe PubMed Central

29 July 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

29 July 2017

35

1 reference

Europe PubMed Central

29 July 2017

6

1 reference

Europe PubMed Central

29 July 2017

1214-1218

1 reference

Europe PubMed Central

29 July 2017

Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

Survey of anaerobic susceptibility patterns in Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility tests

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

Evaluation of two methods for rapid testing for beta-lactamase production in Bacteroides and Fusobacterium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

Prevotella, a new genus to include Bacteroides melaninogenicus and related species formerly classified in the genus Bacteroides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

In vitro susceptibilities of oral pigmented Bacteroides species to trospectomycin and other selected antimicrobial agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284313

21 June 2018

Inhibitory activity of cefotetan and other beta-lactams against anaerobes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1929264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro activity of cefoperazone-sulbactam against Bacteroides species

1 reference

https://pubmed.ncbi.nlm.nih.gov/1929264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of anaerobic bacteria to meropenem

1 reference

https://pubmed.ncbi.nlm.nih.gov/1929264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The growth-inhibitory properties of meropenem against anaerobes of clinical importance

1 reference

https://pubmed.ncbi.nlm.nih.gov/1929264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro susceptibility of the Bacteroides fragilis group and the inoculum effect of newer beta-lactam antibiotics on this group of organisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/1929264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/1929264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres

1 reference

https://pubmed.ncbi.nlm.nih.gov/1929264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity in vitro of cefotetan against non-sporing anaerobes: a comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1929264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.35.6.1214

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33744238&oldid=1630125274"